Zobrazeno 101 - 110
of 200
pro vyhledávání: '"Rainer Schwerdtfeger"'
Autor:
Thomas Luft, Fabio Ciceri, Patrice Chevallier, Avichai Shimoni, Nicolaus Kröger, Didier Blaise, Anja van Biezen, Dietrich W. Beelen, Theo de Witte, Arnold Ganser, Arnon Nagler, Ghulam J. Mufti, Simona Iacobelli, Liisa Volin, Carlos Richard, Rainer Schwerdtfeger, Lothar Kanz, Marie Robin
Publikováno v:
Blood. 124:1216-1216
Allogeneic stem cell transplantation (SCT) is a potentially curative therapy for patients with myelodysplastic syndrome (MDS). So far, there is no proven advantage for any conditioning regimen over the others. Prior studies have shown that reduced-in
Autor:
Joerg Hasford, Markus Pfirrmann, Benjamin Hanfstein, Axel R. Zander, Robert Dengler, Lida Kalmanti, Ernst Holler, G. Schlimok, Dietrich W. Beelen, Alois Gratwohl, Rüdiger Hehlmann, Christiane Falge, Michael Lauseker, Andreas Hochhaus, Renate Arnold, Anthony D. Ho, Hans-Jochem Kolb, Brigitte Schlegelberger, Susanne Saussele, Donald Bunjes, Wolf-Karsten Hofmann, Martin C. Müller, Rainer Schwerdtfeger, Lothar Kanz, Claudia Haferlach, Ulrike Proetel, Susanne Schnittger
Publikováno v:
Blood. 124:2567-2567
Allogeneic HSCT has been established as the only curative treatment option for patients with chronic myeloid leukemia (CML). However, after the advent of tyrosine kinase inhibitors (TKI) the proportion of transplanted patients has decreased dramatica
Autor:
Myriam Labopin, Rainer Schwerdtfeger, C Huber, A. Yaman, A. Burchardt, Nadezda Basara, Karin Kolbe, Herrad Baurmann, Axel A. Fauser
Publikováno v:
Bone marrow transplantation. 35(10)
A total of 155 patients with acute myeloid leukemia (AML) received hematopoietic stem cell transplants from unrelated donors after standard conditioning. Clinical outcome after the use of two different antithymocyte globulins for the prevention of gr
Autor:
Claudia Schoch, B. Rolf, Michael Schleuning, Kolb Hj, Martin Weisser, Georg Ledderose, Rainer Schwerdtfeger, Susanne Schnittger
Publikováno v:
Bone marrow transplantation. 34(12)
Allogeneic bone marrow or stem cell transplantation is a curative therapeutic option for chronic myelogenous leukemia. In order to decrease the toxicity of the procedure, the dosage of total body irradiation was reduced from 12 to 8 Gy and subsequent
Autor:
Klaus, Janitschke, Thomas, Held, Dominique, Krüiger, Rainer, Schwerdtfeger, Gabriele, Schlier, Oliver, Liesenfeld
Publikováno v:
Clinical laboratory. 49(5-6)
The value of Toxoplasma gondii-specific antibodies for the diagnosis of reactivated toxoplasmosis in immunocompromised patients is controversely discussed. The present study was performed to investigate the value of testing for antibodies against Tox
Autor:
Olle Ringdén, Volker Diehl, Martin Bornhaeuser, Axel R. Zander, Christoph Scheid, Bernd Hertenstein, Nicolaus Kroeger, Arnold Ganser, Harts Martin, Mats Remberger, Gerhard Ehninger, Dieter Hoelzer, Michael G. Kiehl, Axel A. Fauser, Rainer Schwerdtfeger, J. Kienast, Ludwig Kraut, Mathias Stelljes
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 22(14)
Purpose The role of unrelated allogeneic stem-cell transplantation in acute lymphoblastic leukemia (ALL) patients is still not clear, and only limited data are available from the literature. We analyzed factors affecting clinical outcome of ALL patie
Autor:
D. W. Beelen, A.R. Zander, Michael G. Kiehl, N Kröger, Tatjana Zabelina, Axel A. Fauser, Rainer Schwerdtfeger, Christian Thiede, Thomas K. Held, Johannes Schetelig, Volker Runde, Wolfgang Siegert, Martin Bornhäuser, G. Ehninger
Publikováno v:
Bone marrow transplantation. 33(5)
It is unknown whether the addition of antithymocyte globulin (ATG) to reduced-intensity conditioning with busulfan (BU) and fludarabine (FLU) is beneficial in HLA-identical sibling transplantation. Therefore, we analyzed retrospectively data on 83 pa
Autor:
Georg Ledderose, Christoph Schmid, Johanna Tischer, Michael Schleuning, Hans-Jochem Kolb, Meike Humann, Rainer Schwerdtfeger, Johanna Ullmann
Prophylactic transfusion of donor lymphocytes (pDLT) is an attractive form of maintenance therapy after allogeneic stem cell transplantation in patients with high risk of relapse. However, clinical experience is limited, and disease response is often
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::753e6445c225ce2fcf5a016578540b38
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/101076
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/101076
Autor:
Dieter Hoelzer, Harald Rieder, Oliver G. Ottmann, Gerhard Ehninger, Patrick Brück, Barbara Wassmann, Heike Pfeifer, Urban J. Scheuring, Thomas Lipp, Johannes Atta, Matthias Stelljes, Lothar Leimer, Harald Gschaidmeier, Claudia Schoch, Jolanta B. Perz, Nicola Gökbuget, Rainer Schwerdtfeger, Anja Binckebanck
Publikováno v:
Blood. 103(4)
Imatinib has pronounced but brief antileukemic activity in advanced Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL). We assessed the prognostic impact of pretreatment disease features and the early bone marrow (BM) response i
Autor:
Tatjana Zabelina, D. W. Beelen, Rudolf Trenschel, Herrad Baurmann, Nicolaus Kröger, Rainer Schwerdtfeger, Axel R. Zander, Ulrich W. Schaefer, M. Bornhäuser, Jürgen Finke, Hellmut Ottinger, Michael Schleuning, Kolb Hj, G. Ehninger, Berger J, Axel A. Fauser, Michael G. Kiehl, Hartmut Bertz
Publikováno v:
Bone marrow transplantation. 32(4)
Matched unrelated donor transplants have an increased risk of severe graft-versus-host disease and transplant-related mortality (TRM). ATG has been introduced to decrease GvHD and to facilitate engraftment. We conducted a retrospective analysis of 33